NCT00777387 Randomized Controlled Trial Comparing Slow-freezing to Vitrification of Oocytes Status TERMINATED Phase NA
NCT00767338 Microsurgical Varicocelectomy Versus No Surgery in Men With a Palpable Varicocele and an Abnormal Semen Analysis Status TERMINATED Phase PHASE3
NCT00745563 Effects of Intra-uterine Slow-Release Insemination on Pregnancy Rate in Women Designated for Artificial Insemination Status COMPLETED Phase NA
NCT00737984 Improving the Pregnancy Rate With Endometrial Sampling Before Intrauterine Insemination Status TERMINATED Phase NA
NCT00736177 Comparison of Transfers of Fresh and Thawed Embryos in Patients With Prior Failed Embryo Transfer Cycles Status WITHDRAWN Phase NA
NCT00730496 Injection of Day 2 Embryo Culture Supernatant Into the Uterine Cavity Didn't Improve Implantation and Pregnancy Rates Status COMPLETED Phase PHASE1
NCT00722618 Communication With in Vitro Fertilization (IVF) Patients About Risks Status COMPLETED Phase NA
NCT00716118 Oocyte Cryopreservation: The Impact of Cryopreservation on the Meiotic Spindle and Mitochondria of Human Oocytes. Status COMPLETED Phase N/A
NCT00713869 Oocyte Cryopreservation: Evaluation of an Oocyte Freezing and Thawing Technique Status UNKNOWN Phase N/A
NCT00712452 Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve Status TERMINATED Phase NA
NCT00708383 in Vitro Fertilization (IVF) Media Protein and Live Birth Rates Status COMPLETED Phase NA
NCT00702845 To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) Status COMPLETED Phase PHASE3
NCT00702806 Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015) Status COMPLETED Phase PHASE2
NCT00702585 Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016) Status COMPLETED Phase PHASE2